Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells.

Liu J, Akanuma N, Liu C, Naji A, Halff GA, Washburn WK, Sun L, Wang P.

Sci Rep. 2016 Aug 3;6:30904. doi: 10.1038/srep30904.

2.

K-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions.

Chiblak S, Steinbauer B, Pohl-Arnold A, Kucher D, Abdollahi A, Schwager C, Höft B, Esposito I, Müller-Decker K.

Sci Rep. 2016 Jul 6;6:29455. doi: 10.1038/srep29455.

3.

A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancer.

Liou GY, Storz P, Leitges M.

Mol Cell Oncol. 2015 Dec 10;3(1):e1035477. doi: 10.1080/23723556.2015.1035477. eCollection 2016 Jan.

PMID:
27308552
4.

Cell Fate Decisions During Breast Cancer Development.

Gross K, Wronski A, Skibinski A, Phillips S, Kuperwasser C.

J Dev Biol. 2016 Mar 1;4(1):4. Epub 2016 Jan 22.

5.

Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis.

Westphalen CB, Takemoto Y, Tanaka T, Macchini M, Jiang Z, Renz BW, Chen X, Ormanns S, Nagar K, Tailor Y, May R, Cho Y, Asfaha S, Worthley DL, Hayakawa Y, Urbanska AM, Quante M, Reichert M, Broyde J, Subramaniam PS, Remotti H, Su GH, Rustgi AK, Friedman RA, Honig B, Califano A, Houchen CW, Olive KP, Wang TC.

Cell Stem Cell. 2016 Apr 7;18(4):441-55. doi: 10.1016/j.stem.2016.03.016.

PMID:
27058937
6.

Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.

Drosos Y, Neale G, Ye J, Paul L, Kuliyev E, Maitra A, Means AL, Washington MK, Rehg J, Finkelstein DB, Sosa-Pineda B.

Neoplasia. 2016 Mar;18(3):172-84. doi: 10.1016/j.neo.2016.02.002.

7.

Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Polvani S, Tarocchi M, Tempesti S, Bencini L, Galli A.

World J Gastroenterol. 2016 Feb 28;22(8):2441-59. doi: 10.3748/wjg.v22.i8.2441. Review.

8.

Notch Signaling in Pancreatic Development.

Li XY, Zhai WJ, Teng CB.

Int J Mol Sci. 2015 Dec 30;17(1). pii: E48. doi: 10.3390/ijms17010048. Review.

9.

Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis.

Karki A, Humphrey SE, Steele RE, Hess DA, Taparowsky EJ, Konieczny SF.

PLoS One. 2015 Dec 30;10(12):e0145724. doi: 10.1371/journal.pone.0145724. eCollection 2015.

10.

Macrophages and pancreatic ductal adenocarcinoma.

Habtezion A, Edderkaoui M, Pandol SJ.

Cancer Lett. 2016 Oct 10;381(1):211-6. doi: 10.1016/j.canlet.2015.11.049. Epub 2015 Dec 18.

PMID:
26708507
11.

Regulation of Cellular Identity in Cancer.

Roy N, Hebrok M.

Dev Cell. 2015 Dec 21;35(6):674-84. doi: 10.1016/j.devcel.2015.12.001. Review.

PMID:
26702828
12.

Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin.

Reichert M, Blume K, Kleger A, Hartmann D, von Figura G.

Stem Cells Int. 2016;2016:9298535. doi: 10.1155/2016/9298535. Epub 2015 Nov 22. Review.

13.

A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting.

Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.

PMID:
26559377
14.

Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.

Sahin IH, Iacobuzio-Donahue CA, O'Reilly EM.

Expert Opin Ther Targets. 2016;20(3):341-59. doi: 10.1517/14728222.2016.1094057. Epub 2015 Oct 6.

15.

Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.

Kuo KK, Kuo CJ, Chiu CY, Liang SS, Huang CH, Chi SW, Tsai KB, Chen CY, Hsi E, Cheng KH, Chiou SH.

Pancreas. 2016 Jan;45(1):71-83. doi: 10.1097/MPA.0000000000000388.

16.

Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract.

Mills JC, Sansom OJ.

Sci Signal. 2015 Jul 14;8(385):re8. doi: 10.1126/scisignal.aaa7540. Review.

17.

The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma.

Krah NM, De La O JP, Swift GH, Hoang CQ, Willet SG, Chen Pan F, Cash GM, Bronner MP, Wright CV, MacDonald RJ, Murtaugh LC.

Elife. 2015 Jul 7;4. doi: 10.7554/eLife.07125.

18.

The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.

Kim S, Lahmy R, Riha C, Yang C, Jakubison BL, van Niekerk J, Staub C, Wu Y, Gates K, Dong DS, Konieczny SF, Itkin-Ansari P.

Pancreas. 2015 Jul;44(5):718-27. doi: 10.1097/MPA.0000000000000328.

19.

Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.

Roy N, Malik S, Villanueva KE, Urano A, Lu X, Von Figura G, Seeley ES, Dawson DW, Collisson EA, Hebrok M.

Genes Dev. 2015 Mar 15;29(6):658-71. doi: 10.1101/gad.256628.114.

20.

Impact of Sox9 dosage and Hes1-mediated Notch signaling in controlling the plasticity of adult pancreatic duct cells in mice.

Hosokawa S, Furuyama K, Horiguchi M, Aoyama Y, Tsuboi K, Sakikubo M, Goto T, Hirata K, Tanabe W, Nakano Y, Akiyama H, Kageyama R, Uemoto S, Kawaguchi Y.

Sci Rep. 2015 Feb 17;5:8518. doi: 10.1038/srep08518.

Items per page

Supplemental Content

Write to the Help Desk